InvestorsHub Logo
Followers 4
Posts 207
Boards Moderated 0
Alias Born 03/06/2022

Re: None

Monday, 01/29/2024 2:32:44 PM

Monday, January 29, 2024 2:32:44 PM

Post# of 459915
FWIW, and I hope I am not repeating what someone else has posted, I noticed today that UBS has just downgraded Biogen (BIIB) from BUY to NEUTRAL and reduced the price target. The analyst says that "inflection" for Leqembi will take longer than anticipated. Substantial sales increase in 2024 is not anticipated.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News